UTHR logo

United Therapeutics (UTHR) Selling, general & administrative expenses

annual SGA:

$638.60M+$161.50M(+33.85%)
December 31, 2024

Summary

  • As of today (May 18, 2025), UTHR annual SGA is $638.60 million, with the most recent change of +$161.50 million (+33.85%) on December 31, 2024.
  • During the last 3 years, UTHR annual SGA has risen by +$171.60 million (+36.75%).
  • UTHR annual SGA is now at all-time high.

Performance

UTHR SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

quarterly SGA:

$170.10M+$7.60M(+4.68%)
March 31, 2025

Summary

  • As of today (May 18, 2025), UTHR quarterly SGA is $170.10 million, with the most recent change of +$7.60 million (+4.68%) on March 31, 2025.
  • Over the past year, UTHR quarterly SGA has increased by +$25.70 million (+17.80%).
  • UTHR quarterly SGA is now -19.50% below its all-time high of $211.30 million, reached on March 31, 2015.

Performance

UTHR quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

TTM SGA:

$28.30B+$1.21B(+4.47%)
March 31, 2025

Summary

  • As of today (May 18, 2025), UTHR TTM SGA is $28.30 billion, with the most recent change of +$1.21 billion (+4.47%) on March 31, 2025.
  • Over the past year, UTHR TTM SGA has increased by +$27.77 billion (+5197.51%).
  • UTHR TTM SGA is now at all-time high.

Performance

UTHR TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

UTHR Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+33.9%+17.8%+5197.5%
3 y3 years+36.8%+115.3%+6499.6%
5 y5 years+90.0%+82.9%+8292.4%

UTHR Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+36.8%-4.2%+115.3%at high+65.4%
5 y5-yearat high+90.0%-4.2%+156.6%at high+114.4%
alltimeall timeat high>+9999.0%-19.5%+1083.2%at high+3730.5%

UTHR Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$170.10M(+4.7%)
$664.30M(+4.0%)
Dec 2024
$638.60M(+33.9%)
$162.50M(+5.5%)
$638.60M(+5.0%)
Sep 2024
-
$154.10M(-13.2%)
$608.30M(+4.6%)
Jun 2024
-
$177.60M(+23.0%)
$581.80M(+8.9%)
Mar 2024
-
$144.40M(+9.2%)
$534.20M(+12.0%)
Dec 2023
$477.10M(-1.0%)
$132.20M(+3.6%)
$477.10M(-6.1%)
Sep 2023
-
$127.60M(-1.8%)
$508.10M(+6.1%)
Jun 2023
-
$130.00M(+48.9%)
$478.90M(-2.3%)
Mar 2023
-
$87.30M(-46.5%)
$490.40M(+1.7%)
Dec 2022
$482.10M(+3.2%)
$163.20M(+65.9%)
$482.10M(+7.9%)
Sep 2022
-
$98.40M(-30.5%)
$446.80M(-2.3%)
Jun 2022
-
$141.50M(+79.1%)
$457.50M(+6.7%)
Mar 2022
-
$79.00M(-38.2%)
$428.80M(-8.2%)
Dec 2021
$467.00M(+10.2%)
$127.90M(+17.2%)
$467.00M(-6.2%)
Sep 2021
-
$109.10M(-3.3%)
$497.80M(+9.4%)
Jun 2021
-
$112.80M(-3.8%)
$455.00M(+1.5%)
Mar 2021
-
$117.20M(-26.1%)
$448.10M(+5.7%)
Dec 2020
$423.90M(+26.1%)
$158.70M(+139.4%)
$423.90M(+14.4%)
Sep 2020
-
$66.30M(-37.4%)
$370.40M(-8.2%)
Jun 2020
-
$105.90M(+13.9%)
$403.50M(+19.7%)
Mar 2020
-
$93.00M(-11.6%)
$337.20M(+0.3%)
Dec 2019
$336.20M(+26.5%)
$105.20M(+5.8%)
$336.20M(+8.4%)
Sep 2019
-
$99.40M(+151.0%)
$310.20M(-3.3%)
Jun 2019
-
$39.60M(-57.0%)
$320.90M(-11.9%)
Mar 2019
-
$92.00M(+16.2%)
$364.40M(+37.1%)
Dec 2018
$265.80M(-19.5%)
$79.20M(-28.1%)
$265.80M(-23.1%)
Sep 2018
-
$110.10M(+32.5%)
$345.70M(+22.2%)
Jun 2018
-
$83.10M(-1359.1%)
$282.80M(+5.9%)
Mar 2018
-
-$6.60M(-104.1%)
$267.10M(-19.1%)
Dec 2017
$330.10M(+4.2%)
$159.10M(+237.1%)
$330.10M(+6.3%)
Sep 2017
-
$47.20M(-30.0%)
$310.50M(-14.6%)
Jun 2017
-
$67.40M(+19.5%)
$363.40M(-1.3%)
Mar 2017
-
$56.40M(-59.6%)
$368.20M(+16.2%)
Dec 2016
$316.80M(-30.0%)
$139.50M(+39.4%)
$316.80M(-2.8%)
Sep 2016
-
$100.10M(+38.6%)
$326.00M(+56.3%)
Jun 2016
-
$72.20M(+1344.0%)
$208.60M(-15.3%)
Mar 2016
-
$5.00M(-96.6%)
$246.40M(-45.6%)
Dec 2015
$452.70M(+18.7%)
$148.70M(-959.5%)
$452.70M(+17.7%)
Sep 2015
-
-$17.30M(-115.7%)
$384.55M(-36.4%)
Jun 2015
-
$110.00M(-47.9%)
$604.35M(+7.5%)
Mar 2015
-
$211.30M(+162.3%)
$562.38M(+47.5%)
Dec 2014
$381.30M(-3.2%)
$80.55M(-60.2%)
$381.30M(-16.7%)
Sep 2014
-
$202.51M(+197.7%)
$457.93M(+31.0%)
Jun 2014
-
$68.03M(+125.2%)
$349.54M(-0.9%)
Mar 2014
-
$30.21M(-80.8%)
$352.87M(-10.4%)
Dec 2013
$394.01M(+95.3%)
$157.18M(+67.0%)
$394.01M(+42.3%)
Sep 2013
-
$94.11M(+31.9%)
$276.90M(+10.1%)
Jun 2013
-
$71.36M(+0.0%)
$251.42M(+7.8%)
Mar 2013
-
$71.36M(+78.1%)
$233.31M(+15.6%)
Dec 2012
$201.75M(+28.9%)
$40.07M(-41.6%)
$201.75M(-8.0%)
Sep 2012
-
$68.63M(+28.9%)
$219.38M(+31.0%)
Jun 2012
-
$53.26M(+33.9%)
$167.41M(+21.3%)
Mar 2012
-
$39.79M(-31.0%)
$138.01M(-11.8%)
DateAnnualQuarterlyTTM
Dec 2011
$156.48M(-17.0%)
$57.71M(+246.5%)
$156.48M(-6.1%)
Sep 2011
-
$16.66M(-30.2%)
$166.68M(-14.8%)
Jun 2011
-
$23.86M(-59.1%)
$195.62M(-2.9%)
Mar 2011
-
$58.26M(-14.2%)
$201.42M(+6.0%)
Dec 2010
$188.61M(+7.0%)
$67.91M(+48.9%)
$190.03M(+6.3%)
Sep 2010
-
$45.59M(+53.7%)
$178.70M(+2.5%)
Jun 2010
-
$29.65M(-36.7%)
$174.28M(-10.2%)
Mar 2010
-
$46.88M(-17.1%)
$194.00M(+10.0%)
Dec 2009
$176.34M(+87.0%)
$56.58M(+37.4%)
$176.34M(+24.5%)
Sep 2009
-
$41.17M(-16.6%)
$141.63M(+8.5%)
Jun 2009
-
$49.37M(+69.0%)
$130.47M(+25.2%)
Mar 2009
-
$29.22M(+33.6%)
$104.19M(+10.5%)
Dec 2008
$94.31M(-4.8%)
$21.86M(-27.2%)
$94.31M(-19.2%)
Sep 2008
-
$30.02M(+30.0%)
$116.67M(+10.3%)
Jun 2008
-
$23.09M(+19.5%)
$105.81M(+2.5%)
Mar 2008
-
$19.33M(-56.3%)
$103.19M(+4.2%)
Dec 2007
$99.03M(+83.3%)
$44.23M(+130.8%)
$99.03M(+33.8%)
Sep 2007
-
$19.16M(-6.4%)
$73.99M(+9.3%)
Jun 2007
-
$20.47M(+35.0%)
$67.72M(+14.6%)
Mar 2007
-
$15.16M(-21.0%)
$59.11M(+9.4%)
Dec 2006
$54.03M(+119.1%)
$19.19M(+48.8%)
$54.03M(+30.2%)
Sep 2006
-
$12.89M(+8.6%)
$41.51M(+21.2%)
Jun 2006
-
$11.87M(+17.8%)
$34.24M(+16.5%)
Mar 2006
-
$10.08M(+51.1%)
$29.39M(+19.2%)
Dec 2005
$24.66M(+14.5%)
$6.67M(+18.7%)
$24.66M(+4.8%)
Sep 2005
-
$5.62M(-20.0%)
$23.53M(+3.5%)
Jun 2005
-
$7.03M(+31.6%)
$22.73M(+7.9%)
Mar 2005
-
$5.34M(-3.7%)
$21.06M(-1.7%)
Dec 2004
$21.53M(-5.0%)
$5.55M(+15.2%)
$21.42M(-2.3%)
Sep 2004
-
$4.82M(-10.1%)
$21.93M(-3.6%)
Jun 2004
-
$5.36M(-6.0%)
$22.74M(-2.7%)
Mar 2004
-
$5.70M(-6.0%)
$23.38M(+3.1%)
Dec 2003
$22.67M(+42.7%)
$6.06M(+7.8%)
$22.67M(+3.6%)
Sep 2003
-
$5.62M(-6.2%)
$21.89M(+9.4%)
Jun 2003
-
$5.99M(+20.1%)
$20.02M(+12.6%)
Mar 2003
-
$4.99M(-5.5%)
$17.78M(+11.9%)
Dec 2002
$15.89M(-6.2%)
$5.28M(+40.9%)
$15.89M(+9.7%)
Sep 2002
-
$3.75M(-0.1%)
$14.48M(-3.9%)
Jun 2002
-
$3.75M(+21.1%)
$15.07M(-1.4%)
Mar 2002
-
$3.10M(-19.9%)
$15.28M(-9.8%)
Dec 2001
$16.94M(+44.4%)
$3.87M(-10.7%)
$16.94M(+0.4%)
Sep 2001
-
$4.34M(+9.4%)
$16.88M(+12.8%)
Jun 2001
-
$3.97M(-16.8%)
$14.97M(+17.9%)
Mar 2001
-
$4.76M(+25.0%)
$12.70M(+8.2%)
Dec 2000
$11.74M(+134.7%)
$3.81M(+57.1%)
$11.74M(+20.7%)
Sep 2000
-
$2.43M(+43.0%)
$9.72M(+14.4%)
Jun 2000
-
$1.70M(-55.4%)
$8.50M(+7.5%)
Mar 2000
-
$3.80M(+111.2%)
$7.90M(+61.2%)
Dec 1999
$5.00M(+108.3%)
$1.80M(+50.0%)
$4.90M(+58.1%)
Sep 1999
-
$1.20M(+9.1%)
$3.10M(+63.2%)
Jun 1999
-
$1.10M(+37.5%)
$1.90M(+137.5%)
Mar 1999
-
$800.00K
$800.00K
Dec 1998
$2.40M
-
-

FAQ

  • What is United Therapeutics annual SGA?
  • What is the all time high annual SGA for United Therapeutics?
  • What is United Therapeutics annual SGA year-on-year change?
  • What is United Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for United Therapeutics?
  • What is United Therapeutics quarterly SGA year-on-year change?
  • What is United Therapeutics TTM SGA?
  • What is the all time high TTM SGA for United Therapeutics?
  • What is United Therapeutics TTM SGA year-on-year change?

What is United Therapeutics annual SGA?

The current annual SGA of UTHR is $638.60M

What is the all time high annual SGA for United Therapeutics?

United Therapeutics all-time high annual SGA is $638.60M

What is United Therapeutics annual SGA year-on-year change?

Over the past year, UTHR annual SGA has changed by +$161.50M (+33.85%)

What is United Therapeutics quarterly SGA?

The current quarterly SGA of UTHR is $170.10M

What is the all time high quarterly SGA for United Therapeutics?

United Therapeutics all-time high quarterly SGA is $211.30M

What is United Therapeutics quarterly SGA year-on-year change?

Over the past year, UTHR quarterly SGA has changed by +$25.70M (+17.80%)

What is United Therapeutics TTM SGA?

The current TTM SGA of UTHR is $28.30B

What is the all time high TTM SGA for United Therapeutics?

United Therapeutics all-time high TTM SGA is $28.30B

What is United Therapeutics TTM SGA year-on-year change?

Over the past year, UTHR TTM SGA has changed by +$27.77B (+5197.51%)
On this page